Pipobroman

Pipobroman
Clinical data
Trade names	Vercite, Vercyte
AHFS/Drugs.com	International Drug Names
ATC code	L01AX02 (WHO) ;
Identifiers
	IUPAC name 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one;
CAS Number	54-91-1 ;
PubChem CID	4842;
IUPHAR/BPS	7271;
DrugBank	DB00236 ;
ChemSpider	4676 ;
UNII	6Q99RDT97R;
KEGG	D00467 ;
ChEBI	CHEBI:8242;
ChEMBL	ChEMBL1585 ;
CompTox Dashboard (EPA)	DTXSID7023485 ;
Chemical and physical data
Formula	C10H16Br2N2O2
Molar mass	356.058 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N1CCN(C(=O)CCBr)CC1)CCBr;
	InChI InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 ; Key:NJBFOOCLYDNZJN-UHFFFAOYSA-N ;
	(verify)

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed in France and Italy.[2]

References

Passamonti F, Lazzarino M (September 2003). "Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman". Leukemia & Lymphoma. 44 (9): 1483–8. doi:10.3109/10428190309178768. PMID 14565648.
"Pipobroman". Drugs.com.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Passamonti F, Lazzarino M (September 2003). "Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman". Leukemia & Lymphoma. 44 (9): 1483–8. doi:10.3109/10428190309178768. PMID 14565648.

[2] "Pipobroman". Drugs.com.